Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $.001 per share
-
Shares outstanding
-
10.5M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
66.1K
-
Shares change
-
-34.3K
-
Total reported value, excl. options
-
$262K
-
Value change
-
-$2.58K
-
Number of buys
-
3
-
Number of sells
-
-8
-
Price
-
$3.97
Significant Holders of SOLIGENIX, INC. - Common Stock, par value $.001 per share (SNGX) as of Q3 2024
13 filings reported holding SNGX - SOLIGENIX, INC. - Common Stock, par value $.001 per share as of Q3 2024.
SOLIGENIX, INC. - Common Stock, par value $.001 per share (SNGX) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.1K shares
of 10.5M outstanding shares and own 0.63% of the company stock.
Largest 10 shareholders include STEPHENS INC /AR/ (46.3K shares), GEODE CAPITAL MANAGEMENT, LLC (18.4K shares), Tower Research Capital LLC (TRC) (930 shares), Plante Moran Financial Advisors, LLC (300 shares), MORGAN STANLEY (224 shares), BANK OF AMERICA CORP /DE/ (19 shares), ALBION FINANCIAL GROUP /UT (1 shares), TRUST CO OF VERMONT (0 shares), UBS Group AG (0 shares), and WELLS FARGO & COMPANY/MN (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.